Reference health
Antibody Development and Disease Severity of Covid-19 in Non-Immunized Patients with Rheumatic Immune-Mediated Inflammatory Diseases: Data from a Prospective Cohort Study
22/22 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
14 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 22 checked references that resolve
resolves10.1093/rheumatology/kes305
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment
resolves10.1016/j.jaut.2021.102632
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark
resolves10.1136/gutjnl-2021-324388
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
resolves10.1126/science.abc5343
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
resolves10.1136/ard.2005.036434
Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers
resolves10.1002/art.30580
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
resolves10.1093/rheumatology/kel366
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients
resolves10.1136/annrheumdis-2020-219498
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
resolves10.1016/j.jclinepi.2014.03.012
False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies
resolves10.3899/jrheum.180153
Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis
resolves10.3899/jrheum.151244
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
resolves10.1007/s10067-021-05675-x
The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia
resolves10.1016/j.jbspin.2020.05.003
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy
resolves10.2147/CLEP.S91125
The Danish National Patient Registry: a review of content, data quality, and research potential
resolves10.1111/dth.14627
The risk for severe
<scp>COVID</scp>
19 in patients with autoimmune and/or inflammatory diseases: First wave lessons
resolves10.1136/annrheumdis-2020-219279
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
resolves10.1002/ana.26028
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
resolves10.1111/j.1600-6143.2006.01288.x
Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action
resolves10.1186/s13075-021-02574-z
Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic
The 14 references without a DOI — listed, not checked
no DOI — not checkedref1
no DOI — not checkedAutoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry
no DOI — not checkedref6
no DOI — not checkedSARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort
no DOI — not checkedref9
no DOI — not checkedref12
no DOI — not checkedAssociation of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis
no DOI — not checkedRisk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
no DOI — not checkedref25
no DOI — not checkedSeverity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
no DOI — not checkedImmunological memory to SARS-CoV-2 assessed for up to 8 months after infection
no DOI — not checkedAnti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19
no DOI — not checkedNational Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Food and Nutrition Board; Committee on the Development of Guiding Principles for the Inclusion of Chronic Disease Endpoints in Future Dietary Reference Intakes
no DOI — not checkedref35
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3937574"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3937574/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3937574)